Understanding the Link Between Diabetes and Fatty Liver Disease
Exploring the Diabetes-Fatty Liver Link: The liver is one of the most crucial organs in our body. Recently, unhealthy lifestyles and poor dietary choices have adversely affected liver health, resulting in a rise in fatty liver disease, especially among those with diabetes. Medical professionals indicate a strong correlation between fatty liver and diabetes. Individuals with fatty liver are at an increased risk of developing Type 2 diabetes, while those with diabetes are more likely to suffer from fatty liver. As a result, many patients find themselves dealing with both conditions at once. In such cases, weight-loss medications can be highly beneficial in alleviating both issues.
Dr. Paras Agarwal, an endocrinologist at Marengo Asia Hospital in Gurugram, shares that the so-called "weight-loss drugs" were initially created for managing Type 2 diabetes. These medications not only promote weight loss but also help in diabetes management. Research has shown that these drugs can effectively treat fatty liver disease as well. The liver acts as the body's glucose reservoir, and when diabetes occurs, insulin resistance leads to fat accumulation in the liver, resulting in fatty liver. The two conditions aggravate each other, making it crucial to manage both effectively.
Dr. Agarwal further explains that individuals with only fatty liver disease can also gain from weight-loss medications. These treatments not only alleviate fatty liver but also significantly lower the risk of developing Type 2 diabetes. Medications, particularly those in the GLP-1 category, help regulate insulin levels and curb appetite. As these drugs promote weight loss, the liver benefits greatly from the reduction in body weight. During this process, the body first uses the excess fat stored in the liver for energy, which decreases liver inflammation and enhances its functionality—an invaluable advantage for those with fatty liver disease.
Experts indicate that there are specific guidelines for prescribing weight-loss medications. A person is eligible for these drugs if their Body Mass Index (BMI) is over 30. Additionally, if someone has a BMI above 27 along with other health issues like high blood pressure, diabetes, or fatty liver disease, doctors may recommend weight-loss treatments or GLP-1 medications. This approach is not solely for weight reduction but also aims to tackle other related health complications. Untreated fatty liver disease can lead to severe conditions like cirrhosis, making weight management a vital therapeutic strategy. However, these medications should only be taken under medical supervision.
PC Social Media